Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Account Payables: 2017-2024

Historic Change in Account Payables for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to -$6.3 million.

  • Kiniksa Pharmaceuticals International's Change in Account Payables fell 399.45% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 128.01%. This contributed to the annual value of -$6.3 million for FY2024, which is 1917.29% down from last year.
  • As of FY2024, Kiniksa Pharmaceuticals International's Change in Account Payables stood at -$6.3 million, which was down 1,917.29% from $347,000 recorded in FY2023.
  • Kiniksa Pharmaceuticals International's 5-year Change in Account Payables high stood at $6.0 million for FY2022, and its period low was -$6.3 million during FY2024.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Change in Account Payables value was $347,000 (recorded in 2023), while the average stood at $24,000.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Change in Account Payables soared by 341.51% in 2022 and then tumbled by 1,917.29% in 2024.
  • Kiniksa Pharmaceuticals International's Change in Account Payables (Yearly) stood at -$5.0 million in 2020, then skyrocketed by 127.49% to $1.4 million in 2021, then spiked by 341.51% to $6.0 million in 2022, then slumped by 94.25% to $347,000 in 2023, then crashed by 1,917.29% to -$6.3 million in 2024.